ISOLATION OF THE HUMAN INTERLEUKIN-10 PROMOTER - CHARACTERIZATION OF THE PROMOTER ACTIVITY IN BURKITTS-LYMPHOMA CELL-LINES

被引:197
|
作者
KUBE, D [1 ]
PLATZER, C [1 ]
VONKNETHEN, A [1 ]
STRAUB, H [1 ]
BOHLEN, H [1 ]
HAFNER, M [1 ]
TESCH, H [1 ]
机构
[1] FRIEDRICH SCHILLER UNIV KLINIKEN,JENA,GERMANY
关键词
HUMAN IL-10 PROMOTER; BURKITTS LYMPHOMA;
D O I
10.1006/cyto.1995.1001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 10 (IL-10) is a pleiotropic growth and differentiation factor with potent suppressor functions on macrophages, T cells and NK cells and contributes to the regulation of proliferation and differentiation of B cells, The expression of IL-10 appears to be tightly regulated, as the levels of constitutive expression in normal cells is extremely low, In contrast to normal haematopoetic cells, Epstein-Barr virus (EBV)-immortalized B cells and EBV-positive Burkitt's lymphoma cells express high levels of IL-10 constitutively, In this report we have cloned and sequenced IL-10 promoter fragments and analysed their activity in EBV-positive Burkitt's lymphoma cells, A nested set of DNA fragments from the IL-10 gene 5'-flanking region was placed upstream of the luciferase gene and assayed for their ability to direct luciferase expression in Burkitt's lymphoma cells, We have identified elements within the 5'-flanking region of the human IL-10 gene which can activate or suppress the constitutive expression of IL-10. The essential promoter of the IL-10 gene, which induces low levels of luciferase expression, was found to require the major start site of transcription (+1), a TATA-box (-77) and up to 150 additional 5' nucleotides, Positive regulatory sequences are located between -1100/-900, Negative regulatory elements which abolish luciferase activity were identified between -8001-300.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [1] CYTOGENETIC STUDIES ON BURKITTS-LYMPHOMA CELL-LINES
    BERNHEIM, A
    BERGER, R
    LENOIR, G
    [J]. CANCER GENETICS AND CYTOGENETICS, 1983, 8 (03) : 223 - 229
  • [2] IMMUNOGLOBULIN SECRETION BY BURKITTS-LYMPHOMA CELL-LINES - REPLY
    BRAUNSTEIN, AH
    KEREN, DF
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1984, 108 (07) : 529 - 529
  • [3] OVER-EXPRESSION OF LCK IN BURKITTS-LYMPHOMA CELL-LINES
    JUCKER, M
    ABTS, H
    EICK, D
    LENOIR, GM
    TESCH, H
    [J]. LEUKEMIA, 1991, 5 (06) : 528 - 530
  • [4] INVASION OF BURKITTS-LYMPHOMA CELL-LINES BY YERSINIA-ENTEROCOLITICA
    ASAI, S
    NAMIKAWA, I
    ITO, Y
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1983, 172 (02): : 243 - 249
  • [5] IMMUNOGLOBULIN DELTA-EXPRESSION IN BURKITTS-LYMPHOMA CELL-LINES
    KIWANUKA, J
    MARTI, G
    MOORE, J
    CHEAH, M
    MAGRATH, I
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (14) : 1075 - 1079
  • [6] INDUCTION OF IGM AND INTERLEUKIN-II PRODUCTION WITH TELEOCIDIN (TCD) IN BURKITTS-LYMPHOMA CELL-LINES
    BENJAMIN, D
    MAGRATH, IT
    HARTMANN, DP
    BAZAR, L
    JACOBSON, RJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 238 - 238
  • [7] HUMAN B-CELL INTERLEUKIN-10 - B-CELL LINES DERIVED FROM PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND BURKITTS-LYMPHOMA CONSTITUTIVELY SECRETE LARGE QUANTITIES OF INTERLEUKIN-10
    BENJAMIN, D
    KNOBLOCH, TJ
    DAYTON, MA
    [J]. BLOOD, 1992, 80 (05) : 1289 - 1298
  • [8] VARIATION IN THE EXPRESSION OF INTERMEDIATE FILAMENTS IN BURKITTS-LYMPHOMA AND HUMAN-LYMPHOBLASTOID CELL-LINES
    MORTAZAVIMILANI, SM
    HOLBOROW, EJ
    [J]. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1983, 11 (07): : 574 - 575
  • [9] P53 IS FREQUENTLY MUTATED IN BURKITTS-LYMPHOMA CELL-LINES
    FARRELL, PJ
    ALLAN, GJ
    SHANAHAN, F
    VOUSDEN, KH
    CROOK, T
    [J]. EMBO JOURNAL, 1991, 10 (10): : 2879 - 2887
  • [10] DIFFERENTIAL REGULATION OF GLYCOSPHINGOLIPID BIOSYNTHESIS IN PHENOTYPICALLY DISTINCT BURKITTS-LYMPHOMA CELL-LINES
    TAGA, S
    MANGENEY, M
    TURSZ, T
    WIELS, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (02) : 261 - 267